Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thermo Fisher Scientific Inc. announced it will invest $97 million to expand its clinical research operations in Richmond, Virginia. The facilities, which include laboratory operations acquired with the purchase of PPD, Inc. in December 2021, will ...
read more
Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a provider of specialty diagnostics, from a shareholder group led by European private equity firm Nordic ...
read more
Further expands service offering to pharma and biotech customers.
read more
Thermo Fisher Scientific and Patheon announced their boards of directors have approved Thermo Fisher's acquisition of Patheon.
read more
Friday, September 07, 2018
Thermo Fisher Scientific has signed a definitive agreement with BD under which Thermo Fisher will acquire BD's Advanced Bioprocessing business.
read more
Thermo Fisher Scientific and QIAGEN announced their boards of directors, as well as the managing board of QIAGEN, have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Thermo Fisher Scientific and Brammer Bio announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.
read more
Thermo Fisher announced it has entered into an agreement with Agios to develop and commercialize a next-generation sequencing oncology companion diagnostic for ivosidenib to identify isocitrate dehydrogenase 1 mutations in cholangiocarcinoma patients...
read more
Wednesday, August 19, 2020
Thermo Fisher has signed a CDx agreement with Hengrui to develop a CDx that will leverage the Oncomine Precision Assay, which runs on the new Ion Torrent Genexus System.
read more
Thermo Fisher has signed agreements with Daiichi Sankyo and Takeda designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs.
read more
Thermo Fisher Scientific has signed an agreement with Janssen Biotech to co-develop a companion diagnostic (CDx) in oncology.
read more
Friday, February 02, 2018
Senior executives in manufacturing operations within large global corporations have selected the Thermo Scientific InSight wireless cold storage monitoring solution as the winner of the 2017 Manufacturing Leaders' Innovation Award.
read more
Wednesday, February 09, 2022
Thermo Fisher Scientific has announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company. Through this partnership, the PPD clinical research business of Thermo Fisher has collaborated with Medidata to develop PPD TrueCast, ...
read more
Monday, September 14, 2020
Thermo Fisher Scientific has announced the opening of its new Bioprocessing Collaboration Center in St. Louis, Missouri.
read more